Besides, considering previous studies in CRC, lung cancer and pancreatic cancer [9, 14, 41], whether LINC01133 might bind certain proteins or regulate other pathways to exert its inhibitory effect on GC progression remains mysterious. This evidence concerns the gene LINC01133 and lung carcinoma.